Average Co-Inventor Count = 4.08
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enzo Life Sciences, Inc. (14 from 98 patents)
2. Enzo Biochem, Inc. (8 from 81 patents)
3. Enzo Therapeutics, Inc. (5 from 31 patents)
4. Enzo Life Science, Inc. C/o Enzo Biochem Inc. (1 from 1 patent)
28 patents:
1. 10144957 - Optimized real time nucleic acid detection processes
2. 10144956 - Processes for quantitative or qualitative detection of single-stranded or double-stranded nucleic acids
3. 9492419 - Method for treating crohn'S disease or ulcerative colitis by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
4. 9353405 - Optimized real time nucleic acid detection processes
5. 9316587 - Processes for quantitative or qualitative detection of single-stranded or double-stranded nucleic acids
6. 9261460 - Real-time nucleic acid detection processes and compositions
7. 9068948 - Processes for detection of nucleic acids
8. 9052324 - Compounds and assays for controlling Wnt activity
9. 9046537 - Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
10. 8969339 - Compositions and methods for bone formation and modeling
11. 8846952 - Detection or quantification of desirable target molecules, novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes
12. 8846893 - Non-ionically bound constructs, and compositions and kits comprising domains
13. 8759526 - Dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes—useful or detection or quantification of desirable target molecules
14. 8742090 - Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses
15. 8735145 - Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses